COST-EFFECTIVENESS ANALYSIS OF TREATMENT FOR SEVERE EOSINOPHILIC ASTHMA IN ADULTS: MEPOLIZUMAB AND OMALIZUMAB ArticleTolkushin A.G., Pogudina N.L., Ivanov D.A., Demko I.V.Medical Technologies. Assessment and Choice. Том 35. 2019. С. 74-86
